Antiretroviral therapy coverage for PMTCT in Egypt
Egypt: Antiretroviral therapy coverage for PMTCT was 27.0% in 2024. ◆ Volatile
Antiretroviral therapy coverage for PMTCT in Egypt, 2000–2024
Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of pregnant women living with HIV.
Analysis
In 2024, antiretroviral therapy coverage for pmtct in Egypt stood at 27.0%.
Compared with earlier readings it is up 35.0% on the previous year and up 200.0% over ten years.
Over the whole period, antiretroviral therapy coverage for pmtct in Egypt peaked at 31.0% in 2021 and was at its lowest, 0.0%, in 2000.
Egypt ranks 79th of 84 countries on this measure, in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Antiretroviral therapy coverage for PMTCT in Egypt, year by year
| Year | % of pregnant women living with HIV | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 1.0% | — |
| 2005 | 1.0% | +0.0% |
| 2006 | 2.0% | +100.0% |
| 2007 | 1.0% | -50.0% |
| 2008 | 0.0% | -100.0% |
| 2009 | 2.0% | — |
| 2010 | 3.0% | +50.0% |
| 2011 | 2.0% | -33.3% |
| 2012 | 3.0% | +50.0% |
| 2013 | 11.0% | +266.7% |
| 2014 | 9.0% | -18.2% |
| 2015 | 9.0% | +0.0% |
| 2016 | 14.0% | +55.6% |
| 2017 | 14.0% | +0.0% |
| 2018 | 15.0% | +7.1% |
| 2019 | 17.0% | +13.3% |
| 2020 | 18.0% | +5.9% |
| 2021 | 31.0% | +72.2% |
| 2022 | 30.0% | -3.2% |
| 2023 | 20.0% | -33.3% |
| 2024 | 27.0% | +35.0% |
Egypt compared with similar countries
- Egypt's 27.0% is below the median for lower middle income countries, which is 83.5%, 32% of the median. (32 countries reporting)
- Egypt's 27.0% is below the median for Middle East, North Africa, Afghanistan & Pakistan, which is 32.0%, 84% of the median. (9 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.7% | 0.0% | 2.0% | 10 |
| 2010s | 9.7% | 2.0% | 17.0% | 10 |
| 2020s | 25.2% | 18.0% | 31.0% | 5 |
Countries ranked near Egypt
- 77 Madagascar 30.0% compare
- 78 Papua New Guinea 28.0% compare
- 80 Philippines 16.0% compare
- 81 Afghanistan 14.0% compare
- 81 Pakistan 14.0% compare
More health data for Egypt
- Un projection of annual infant deaths, annual growth rate -1.46 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.7884 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 946 deaths per 1,000 people (2090)
- Number of infants who die before age 1 7,225 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 0.3993 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0487 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.4524 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is antiretroviral therapy coverage for pmtct in Egypt?
- Antiretroviral therapy coverage for pmtct in Egypt was 27.0% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
- What is the highest antiretroviral therapy coverage for pmtct recorded in Egypt?
- The highest recorded value was 31.0% in 2021.
- What is the lowest antiretroviral therapy coverage for pmtct recorded in Egypt?
- The lowest recorded value was 0.0% in 2000.
- How does Egypt rank for antiretroviral therapy coverage for pmtct?
- Egypt ranks 79th out of 84 countries with data for 2024.
- Is antiretroviral therapy coverage for pmtct rising or falling in Egypt?
- Over the last ten years it is up 200.0%. The long-run trend across the full record is volatile.
- Where does this Egypt data come from?
- The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).